Cross-talk of inflammation and cellular senescence: a new insight into the occurrence and progression of osteoarthritis
Перекрестное взаимодействие воспаления и клеточного старения: новый взгляд на возникновение и прогрессирование остеоартрита
2024-12-03
SCID: 54.1/b2e2emcr
Discuss with AI
cellular senescenceinflammationosteoarthritissenescence-associated secretory phenotype (SASP)senolytic therapy
Figures from the paper
Abstract (AI)
Osteoarthritis (OA) poses a significant challenge in orthopedics. Inflammatory pathways are regarded as central mechanisms in the onset and progression of OA. Growing evidence suggests that senescence acts as a mediator in inflammation-induced OA. Given the lack of effective treatments for OA, there is an urgent need for a clearer understanding of its pathogenesis. In this review, we systematically summarize the cross-talk between cellular senescence and inflammation in OA. We begin by focusing on the mechanisms and hallmarks of cellular senescence, summarizing evidence that supports the relationship between cellular senescence and inflammation. We then discuss the mechanisms of interaction between cellular senescence and inflammation, including senescence-associated secretory phenotypes (SASP) and the effects of pro- and anti-inflammatory interventions on cellular senescence. Additionally, we focus on various types of cellular senescence in OA, including senescence in cartilage, subchondral bone, synovium, infrapatellar fat pad, stem cells, and immune cells, elucidating their mechanisms and impacts on OA. Finally, we highlight the potential of therapies targeting senescent cells in OA as a strategy for promoting cartilage regeneration.
Key Findings
1
Cellular senescence and inflammation interact bidirectionally through senescence-associated secretory phenotypes and the effects of pro- and anti-inflammatory interventions.
2
Cellular senescence occurs across cartilage, subchondral bone, synovium, infrapatellar fat pad, stem cells, and immune cells, influencing osteoarthritis mechanisms and progression.
3
Inflammatory pathways are central to osteoarthritis onset and progression, with cellular senescence increasingly implicated as a mediator of inflammation-induced disease.
4
Targeting senescent cells is identified as a potential therapeutic strategy for osteoarthritis and may promote cartilage regeneration.
5
The review emphasizes that clarifying senescence–inflammation cross-talk could improve understanding of osteoarthritis pathogenesis and support development of more effective treatments.
Research Object
Osteoarthritis and its affected joint tissues and cells, including cartilage, subchondral bone, synovium, infrapatellar fat pad, stem cells, and immune cells
Research Subject
The bidirectional cross-talk between inflammation and cellular senescence in the onset and progression of osteoarthritis, including SASP-mediated mechanisms and therapeutic targeting of senescent cells
Publication Details
Publication Date
2024-12-03
Journal
Publisher
ISSN
Cited by
215
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest